NCT05996276 2024-08-09
SATIATION
University Hospital, Brest
Unknown
Clinical Trials
44 trialsNCT04939883 2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4 Unknown
NCT04852965 2024-02-20
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors
Queen's University, Belfast
Unknown
NCT05880160 2023-12-04
HER-SAFE
University College, London
Phase NA Unknown
NCT05159479 2023-09-21
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity
University College, London
Unknown
NCT06048458 2023-09-21
PC-TOX
University College, London
Unknown
NCT06005259 2023-08-22
SPIROTOX
University of Sao Paulo
Phase 4 Unknown
NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
NCT03882580 2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
NCT05746598 2023-02-28
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
Ain Shams University
Unknown
NCT05728632 2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3 Unknown
NCT05733026 2023-02-17
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
Ain Shams University
Unknown
NCT05454553 2022-11-29
EDIPE
Institut de cancérologie Strasbourg Europe
Phase NA Unknown
NCT05146843 2022-04-08
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
D'Or Institute for Research and Education
Phase NA Unknown
NCT05298072 2022-03-28
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
University Hospital, Essen
Unknown
NCT03186404 2022-02-08
SPARE-HF
University Health Network, Toronto
Phase 2 Unknown
NCT02236806 2022-02-01
SAFE
Azienda Ospedaliero-Universitaria Careggi
Phase 3 Unknown
NCT05150080 2021-12-08
EIECC
Qianfoshan Hospital
Unknown
NCT05063643 2021-10-01
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude
Affiliated Hospital of Qinghai University
Unknown
NCT05019365 2021-08-24
Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy
University of Glasgow
Unknown
NCT04867564 2021-07-23
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy
Military Institute od Medicine National Research Institute
Unknown
NCT04962425 2021-07-15
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Peking University Third Hospital
Unknown
NCT04961307 2021-07-14
Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab
Peking University Third Hospital
Unknown
NCT04939857 2021-06-25
Effect of Trimetazidine on Radiotherapy-induced Heart Damage.
Peking University Third Hospital
Phase 2/3 Unknown
NCT04885088 2021-05-13
AI
Taipei Medical University Shuang Ho Hospital
Unknown
NCT04632407 2020-11-17
CANFLAX
St. Boniface Hospital
Phase NA Unknown
NCT04461223 2020-07-08
Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04461392 2020-07-08
Exercise Response After Revalidation in Cancer Patients
Universitair Ziekenhuis Brussel
Phase NA Unknown
NCT04429633 2020-06-12
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Samsung Medical Center
Phase NA Unknown
NCT02471885 2020-04-15
ERIC-ONC
University College, London
Phase NA Unknown
NCT04092309 2020-04-03
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
University of Athens
Phase NA Unknown
NCT04046315 2020-03-16
EARLY-CATCH
Radboud University Medical Center
Unknown
NCT04030546 2019-12-18
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
Vilnius University
Phase 3 Unknown
NCT03155802 2019-11-01
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Stony Brook University
Unknown
NCT04047901 2019-08-07
Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment
University of Sao Paulo General Hospital
Phase NA Unknown
NCT01032278 2019-05-21
Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)
M.D. Anderson Cancer Center
Phase NA Unknown
NCT03650205 2019-04-02
IPAC
University of Sao Paulo
Phase NA Unknown
NCT02571894 2018-03-07
COBC
Karolinska University Hospital
Phase NA Unknown
NCT01022086 2017-07-12
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unity Health Toronto
Unknown
NCT02052102 2017-01-06
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
AHS Cancer Control Alberta
Phase 2 Unknown
NCT01016886 2016-02-09
MANTICORE
AHS Cancer Control Alberta
Phase 1/2 Unknown
NCT02220569 2015-09-23
PULSE-ECCho
McGill University Health Centre/Research Institute of the McGill University Health Centre
Unknown
NCT02101879 2014-05-02
Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes
Rambam Health Care Campus
Unknown
NCT01246856 2011-09-12
TOXTAC
Radboud University Medical Center
Unknown